AYA: Operating momentum meets development risk
AYA analysis of Zgounder operating momentum and Boumadine development risk.
CAMS Premium Report
VICR: Guidance stepped up, and valuation already expects durability
VICR analysis of raised guidance, licensing economics, and a demanding valuation.
FSLY: AI control meets a stretched tape
CAMS Premium research on Fastly.
AYI: A mixed setup before the next earnings test
CAMS Premium research on Acuity.
MKC: Margin quality meets combination risk
CAMS Premium research on McCormick.
ACN: Accenture at the October inflection point
CAMS Premium research on Accenture.
CLDX: Replicated Phase 3 efficacy, unfinished commercial proof
CAMS Premium research on Celldex Therapeutics.
JBL: Earnings week tests an AI-driven rerating
CAMS Premium research on Jabil.
CAG: A low multiple meets a demanding stabilization test
CAMS Premium research on Conagra Brands.
MU: Earnings durability meets cycle risk after an exceptional rerating
CAMS Premium research on Micron Technology.